Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jawahar Mehta to Hypertension

This is a "connection" page, showing publications Jawahar Mehta has written about Hypertension.

 
Connection Strength
  
 
 
7.253
  
  1. Salah HM, Mehta JL. Best time for administration of antihypertensive medications: morning or evening? Lancet. 2022 10 22; 400(10361):1383-1385.
    View in: PubMed
    Score: 0.583
  2. Babaahmadi-Rezaei H, Rezaei M, Ghaderi-Zefrehi H, Azizi M, Beheshti-Nasab H, Mehta JL. Reducing Proteoglycan Synthesis and NOX Activity by ROCK Inhibitors: Therapeutic Targets in Atherosclerosis. Endocr Metab Immune Disord Drug Targets. 2022; 22(12):1191-1200.
    View in: PubMed
    Score: 0.552
  3. Mathur P, Kadavath S, Marsh JD, Mehta JL. Chronotherapy for hypertension: improvement in patient outcomes with bedtime administration of antihypertensive drugs. Eur Heart J. 2020 12 21; 41(48):4577-4579.
    View in: PubMed
    Score: 0.514
  4. Salah HM, Arthur JM, Mehta JL. Implications of renal ACE2 expression in the age of COVID-19. Eur Heart J. 2020 12 21; 41(48):4589-4591.
    View in: PubMed
    Score: 0.514
  5. Sharma T, Mathur P, Mehta JL. Daytime or Nighttime Administration of Antihypertensive Medications? Am J Hypertens. 2020 11 03; 33(11):987-989.
    View in: PubMed
    Score: 0.510
  6. Salah HM, Calcaterra G, Mehta JL. Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):503-507.
    View in: PubMed
    Score: 0.501
  7. Saad M, Salehi N, Ding Z, Mehta JL. Blood pressure target in diabetics: how low is too low? Eur Heart J. 2019 07 01; 40(25):2044-2046.
    View in: PubMed
    Score: 0.464
  8. Pothineni NVK, Mehta JL. Assessing medication adherence: a new quality metric? J Hypertens. 2019 04; 37(4):683-684.
    View in: PubMed
    Score: 0.456
  9. Ayyadevara S, Mercanti F, Wang X, Mackintosh SG, Tackett AJ, Prayaga SV, Romeo F, Shmookler Reis RJ, Mehta JL. Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles. Hypertension. 2016 May; 67(5):1006-13.
    View in: PubMed
    Score: 0.369
  10. Ding Z, Liu S, Wang X, Khaidakov M, Fan Y, Deng X, Xiang D, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 regulates autophagy and Toll-like receptor 4 in the brain of hypertensive mice. J Hypertens. 2015 Mar; 33(3):525-33; discussion 533.
    View in: PubMed
    Score: 0.344
  11. Mehta JL, Ding Z, Liu S, Wang X, Khaidakov M. Hypertension, TLR4 activation in brain and cardiac hypertrophy. Cardiovasc Res. 2014 Jul 01; 103(1):3-4.
    View in: PubMed
    Score: 0.325
  12. Deshmukh A, Pant S, Kumar G, Murugiah K, Mehta J. Seasonal variation in hypertensive emergency hospitalization. J Clin Hypertens (Greenwich). 2012 Apr; 14(4):269-70.
    View in: PubMed
    Score: 0.279
  13. Deshmukh A, Kumar G, Kumar N, Nanchal R, Gobal F, Sakhuja A, Mehta JL. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol. 2011 Nov 01; 108(9):1277-82.
    View in: PubMed
    Score: 0.270
  14. Hu C, Dandapat A, Sun L, Marwali MR, Inoue N, Sugawara F, Inoue K, Kawase Y, Jishage K, Suzuki H, Hermonat PL, Sawamura T, Mehta JL. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension. 2008 Sep; 52(3):556-62.
    View in: PubMed
    Score: 0.217
  15. Sarkar K, Sinha AK, Mehta JL. The role of statins in endothelial dysfunction in hypertension. Curr Opin Cardiol. 2006 Jul; 21(4):316-21.
    View in: PubMed
    Score: 0.189
  16. Sukhija R, Kakar P, Mehta V, Mehta JL. Enhanced 11beta-hydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic hypertension. Am J Cardiol. 2006 Aug 15; 98(4):544-8.
    View in: PubMed
    Score: 0.188
  17. Chen J, Mehta JL. Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease. Curr Hypertens Rep. 2006 May; 8(2):139-43.
    View in: PubMed
    Score: 0.186
  18. Singh BM, Mehta JL. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med. 2003 Jun 09; 163(11):1296-304.
    View in: PubMed
    Score: 0.153
  19. Salah HM, Mehta JL. Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):114-118.
    View in: PubMed
    Score: 0.127
  20. Wang X, Khaidakov M, Ding Z, Mitra S, Lu J, Dai Y, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and cardiac fibroblast growth. Hypertension. 2012 Dec; 60(6):1437-42.
    View in: PubMed
    Score: 0.073
  21. Luo P, Yan M, Frohlich ED, Mehta JL, Hu C. Novel concepts in the genesis of hypertension: role of LOX-1. Cardiovasc Drugs Ther. 2011 Oct; 25(5):441-9.
    View in: PubMed
    Score: 0.068
  22. Hu C, Kang BY, Megyesi J, Kaushal GP, Safirstein RL, Mehta JL. Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int. 2009 Sep; 76(5):521-7.
    View in: PubMed
    Score: 0.058
  23. Sukhija R, Prayaga S, Marashdeh M, Bursac Z, Kakar P, Bansal D, Sachdeva R, Kesan SH, Mehta JL. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med. 2009 Mar; 57(3):495-9.
    View in: PubMed
    Score: 0.057
  24. Han P, Shen FM, Xie HH, Chen YY, Miao CY, Mehta JL, Sassard J, Su DF. The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats. J Cell Mol Med. 2009 Apr; 13(4):726-34.
    View in: PubMed
    Score: 0.057
  25. Mohandas B, Mehta JL. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Curr Opin Cardiol. 2007 Sep; 22(5):434-42.
    View in: PubMed
    Score: 0.051
  26. Bansal D, Chahoud G, Smith ES, Mehta JL. Prevention of heart failure. Curr Opin Cardiol. 2006 Sep; 21(5):510-6.
    View in: PubMed
    Score: 0.048
  27. Mehta JL. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. Can J Cardiol. 2004 Aug; 20 Suppl B:32B-36B.
    View in: PubMed
    Score: 0.041
  28. Chen P, Yang F, Wang W, Li X, Liu D, Zhang Y, Yin G, Lv F, Guo Z, Mehta JL, Wang X. Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):179-188.
    View in: PubMed
    Score: 0.031
  29. Zhang LL, Zhang Y, Cheng YQ, Zhang JM, Liu HQ, Wang WZ, Mehta JL, Xiong ZG, Su DF, Liu AJ. Metabolic syndrome emerges after artificial selection for low baroreflex sensitivity. CNS Neurosci Ther. 2018 09; 24(9):828-836.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.